ZOETIS BELGIUM
0401.953.350 · rovalta.com · 20/09/2026
ZOETIS BELGIUM
Overview
What does ZOETIS BELGIUM do?
ZOETIS BELGIUM is a Public limited company incorporated in 1950. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Ottignies-Louvain-la-Neuve. It employs on average 867,5 ETP workers (FTE).
1348 Ottignies-Louvain-la-Neuve · WallonieSee on map
Joint committees (2)
- 116
- 207
Trend over 11 financial years
| 2021 | 2020 | 2019 | 2018 | 2017 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||
| Revenue | 3,2 Md € | +18.0% | 2,7 Md € | +10.0% | 2,5 Md € | +5.0% | 2,3 Md € | +10.9% | 2,1 Md € | +2145% | 94,0 M € | +31.3% | 71,5 M € | -31.7% | 104,7 M € | +25.4% | 83,5 M € | -1.6% | 84,9 M € | -3.8% | 88,2 M € |
| EBITDA | 985,3 M € | +26.6% | 778,4 M € | +8.6% | 716,6 M € | +6.7% | 671,8 M € | +26.2% | 532,3 M € | +2948% | 17,5 M € | -40.0% | 29,1 M € | -51.2% | 59,6 M € | +115% | 27,7 M € | +20.1% | 23,1 M € | -7.3% | 24,9 M € |
| Operating result | 955,9 M € | +31.3% | 728,0 M € | +12.1% | 649,2 M € | +7.1% | 606,4 M € | +25.7% | 482,5 M € | +39365% | -1,2 M € | -123% | 5,4 M € | -85.9% | 38,2 M € | +137% | 16,1 M € | -0.8% | 16,3 M € | +19.0% | 13,7 M € |
| Net result | 857,8 M € | +18.6% | 723,3 M € | +31.0% | 552,1 M € | +8.5% | 508,9 M € | +23.1% | 413,2 M € | +11126% | -3,7 M € | -255% | 2,4 M € | -89.9% | 23,8 M € | +134% | 10,1 M € | +1.5% | 10,0 M € | +28.2% | 7,8 M € |
| Balance sheet | |||||||||||||||||||||
| Equity | 1,7 Md € | +27.6% | 1,3 Md € | +15.4% | 1,1 Md € | +4.8% | 1,1 Md € | -15.1% | 1,3 Md € | +999% | 115,4 M € | -3.2% | 119,2 M € | +5.9% | 112,5 M € | +26.7% | 88,8 M € | +12.8% | 78,8 M € | +14.4% | 68,8 M € |
| Total assets | 2,2 Md € | +21.8% | 1,8 Md € | +20.2% | 1,5 Md € | -4.6% | 1,6 Md € | -6.5% | 1,7 Md € | +634% | 228,5 M € | -6.5% | 244,4 M € | -4.5% | 255,9 M € | +3.7% | 246,8 M € | +75.9% | 140,4 M € | +16.1% | 120,9 M € |
| Cash | 3,4 M € | -97.5% | 139,2 M € | +62.4% | 85,7 M € | -40.6% | 144,4 M € | -1.1% | 146,0 M € | +138626% | 105,3 k € | -92.7% | 1,4 M € | +3599% | 39,1 k € | -76.8% | 168,4 k € | -95.8% | 4,0 M € | +279% | 1,1 M € |
| Debts | 500,0 M € | +7.5% | 465,0 M € | +35.6% | 343,0 M € | -26.4% | 466,1 M € | +24.2% | 375,2 M € | +250% | 107,3 M € | -12.3% | 122,3 M € | -13.2% | 140,9 M € | -9.6% | 155,9 M € | +162% | 59,5 M € | +17.9% | 50,4 M € |
| Other | |||||||||||||||||||||
| Workforce | 867,5 ETP | +58.5% | 547,3 ETP | +6.5% | 514,0 ETP | +2.1% | 503,2 ETP | -1.4% | 510,6 ETP | +106% | 248,2 ETP | -2.3% | 254,0 ETP | +0.5% | 252,7 ETP | 0.0% | 252,7 ETP | -3.7% | 262,4 ETP | -2.3% | 268,6 ETP |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 30/11/2011 · 4 active · 14 ended
Active mandates
Ended mandates
Financials
Full financial information
| 2025 | 2025 | 2024 | 2024 | 2023 | 2023 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | m120-f-p | Full model | m121-f-p | Full model |
| Start of the financial year | 01/12/2025 | 01/12/2024 | 01/01/2024 | 01/12/2023 | 01/01/2023 | 01/12/2022 |
| Closing of the financial year | 31/12/2025 | 30/11/2025 | 31/12/2024 | 30/11/2024 | 31/12/2023 | 30/11/2023 |
| Length of the financial year | 1 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 05/06/2026 | 05/06/2026 | 05/06/2025 | 05/06/2025 | 06/06/2024 | 06/06/2024 |
| General meeting | 29/05/2026 | 29/05/2026 | 21/05/2025 | 30/05/2025 | 22/05/2024 | 31/05/2024 |
| Currency of the financial year | USD | USD | USD | USD | USD | USD |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
26 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 29/05/2026 | 05/06/2026 | French | |
| m120-f-p | 31/12/2025 | 20/05/2026 | 05/06/2026 | French | |
| Full model | 30/11/2025 | 29/05/2026 | 05/06/2026 | French | |
| m120-f-p | 31/12/2024 | 21/05/2025 | 05/06/2025 | French | |
| Full model | 30/11/2024 | 30/05/2025 | 05/06/2025 | French | |
| m121-f-p | 31/12/2023 | 22/05/2024 | 06/06/2024 | French | |
| Full model | 30/11/2023 | 31/05/2024 | 06/06/2024 | French | |
| m121-f-p | 31/12/2022 | 18/05/2023 | 06/06/2023 | French | |
| Full model | 30/11/2022 | 26/05/2023 | 06/06/2023 | French | |
| m120-f-p | 31/12/2021 | 19/05/2022 | 20/01/2023 | French | |
| Full model | 30/11/2021 | 27/05/2022 | 13/06/2022 | French | |
| Full model | 30/11/2020 | 28/05/2021 | 10/06/2021 | French | |
| Full model | 30/11/2019 | 29/05/2020 | 15/06/2020 | French | |
| Full model | 30/11/2018 | 24/05/2019 | 12/06/2019 | French | |
| Full model | 30/11/2017 | 24/05/2018 | 13/06/2018 | French | |
| Full model | 30/11/2016 | 28/06/2017 | 29/06/2017 | French | |
| Full model | 30/11/2015 | 23/06/2016 | 24/06/2016 | French | |
| Full model | 30/11/2014 | 09/07/2015 | 27/07/2015 | French | |
| Full model | 30/11/2013 | 18/06/2014 | 22/07/2014 | French | |
| Full model | 30/11/2012 | 19/06/2013 | 26/06/2013 | French | |
| Full model | 30/11/2011 | 16/04/2012 | 01/06/2012 | French | |
| Full model | 30/11/2010 | 03/05/2011 | 14/06/2011 | French | |
| Full model | 30/11/2009 | 03/05/2010 | 03/06/2010 | French | |
| Full model | 30/11/2008 | 04/05/2009 | 04/06/2009 | French |
Valuation
Indicative valuation
As an indication, this company is worth
more than 1.000 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 30/11/2011 · 4 active · 14 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Capital / shares19/12/2025CAPITAL, ACTIONS
- Mandates04/12/2025DEMISSIONS, NOMINATIONS
- Mandates04/12/2025DEMISSIONS, NOMINATIONS
- Mandates08/07/2025DEMISSIONS, NOMINATIONS
- Other14/05/2025ANNEE COMPTABLE - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Other14/05/2025BOEKJAAR - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates07/05/2025DEMISSIONS, NOMINATIONS
- Mandates14/02/2025DEMISSIONS, NOMINATIONS
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 24/07/2025nominationMartine Lanssens — administrateur
- 30/05/2025nominationKPMG Réviseurs d'Entreprises BV/SRL — commissaire
- 30/04/2025nominationStephanie Armstrong — représentante autorisée de la succursale de Singapour
- 30/04/2025nominationAdrian Pratt — Directeur régional pour l'Afrique
- 30/04/2025nominationFadila Mekideche — Directrice générale Afrique Nord-Ouest et Est
- 30/04/2025nominationTetiana Miroshnychenko — Responsable de l'initiative ALPHA Plus
- 30/04/2025nominationMark Worsman — conseiller juridique
- 30/04/2025nominationPooja Rajan — conseiller juridique
- 30/04/2025nominationThinh Le Hoang — conseiller juridique
- 15/10/2024nominationWilliam Connell — pouvoirs spéciaux
- 15/10/2024nominationVeera Pienimäki — pouvoirs spéciaux
- 15/10/2024nominationMohamed Youssef — pouvoirs spéciaux
- 15/10/2024nominationFrédéric Descamps — pouvoirs spéciaux
- 15/10/2024nominationElke De Swaef — pouvoirs spéciaux
- 16/07/2024nominationJohan Aeyels — pouvoirs spéciaux
- 19/02/2024nominationGondje Hendriks — directeur général
- 08/01/2024nominationGondje Hendriks — administrateur
- 18/10/2023revocationSimon Brown — pouvoirs spéciaux
- 18/10/2023revocationSiew Nee Ivy Ong — pouvoirs spéciaux
- 18/10/2023revocationTheo Kanellos — pouvoirs spéciaux
- 18/10/2023revocationTodd O'Donnell — pouvoirs spéciaux
- 18/10/2023revocationCarlos Leopardi — pouvoirs spéciaux
- 18/10/2023revocationJohn Mahon — pouvoirs spéciaux
- 18/10/2023revocationNathalia Valencia — pouvoirs spéciaux
- 18/10/2023revocationMalgorzata Gawek — pouvoirs spéciaux
- 18/10/2023nominationScott Mayhew — Chief Patent Counsel par intérim, Global Intellectual Property (pouvoirs spéciaux)
- 18/10/2023nominationJason McBrayer — pouvoirs spéciaux
- 18/10/2023nominationNeils Sorensen — pouvoirs spéciaux
- 18/10/2023nominationJulian Aymans — pouvoirs spéciaux
- 18/10/2023nominationTetiana Miroshnychenko — pouvoirs spéciaux
- 18/10/2023nominationHao Xin Neo — pouvoirs spéciaux
- 18/10/2023nominationIvy Lee Hoon Ong — pouvoirs spéciaux
- 18/10/2023nominationRegina Teo Liting — pouvoirs spéciaux
- 18/10/2023nominationPaulina Ortega Bianchini — pouvoirs spéciaux
- 18/10/2023nominationAnass Benbouidda — pouvoirs spéciaux
- 18/10/2023nominationBorbala Galek — pouvoirs spéciaux
- 18/10/2023nominationGraziela Ferro Campiolo — pouvoirs spéciaux
- 18/10/2023nominationAlessandra Liermann — pouvoirs spéciaux
- 18/10/2023nominationBilikis Sulaimon — pouvoirs spéciaux
- 18/10/2023nominationNele Sente — pouvoirs spéciaux
- 18/10/2023nominationIrina Laskov — pouvoirs spéciaux
- 18/10/2023nominationOliver Boucher — pouvoirs spéciaux (extension)
- 28/06/2023autre
- 21/02/2023nominationNick Ashton — président du conseil d'administration
- 26/10/2022nominationSaily John — pouvoirs spéciaux
- 26/10/2022nominationPatrick Onen — pouvoirs spéciaux
- 26/10/2022nominationCelia Lopez — pouvoirs spéciaux
- 26/10/2022nominationEila Leikind — pouvoirs spéciaux
- 26/10/2022nominationRoopa Kommajosyuia — pouvoirs spéciaux
- 26/10/2022nominationEdward DuBeau — pouvoirs spéciaux
- 26/10/2022nominationNailya Nadershina — mandat relatif aux formalités de dépôt et de publication légale
- 2021Annual accounts 2021857,8 M €↑
- 2020Annual accounts 2020723,3 M €↑
- 2019Annual accounts 2019552,1 M €↑
- 2018Annual accounts 2018508,9 M €↑
- 2017Annual accounts 2017413,2 M €↑
- 2017Name changeZOETIS BELGIUM
- 2011Annual accounts 2011-3,7 M €↓
- 2010Annual accounts 20102,4 M €↓
- 2009Annual accounts 200923,8 M €↑
- 2008Annual accounts 200810,1 M €↑
- 2007Annual accounts 200710,0 M €↑
- 2006Annual accounts 20067,8 M €
- 2006Name changePfizer Animal Health
- 15/02/1950IncorporationPublic limited company